Skip to main content

Table 6 Percent of patients with reached PA-level ≥ 5p at 6-month follow-up, analysed with 1–2 baseline predictive correlates

From: Which patients benefit from physical activity on prescription (PAP)? A prospective observational analysis of factors that predict increased physical activity

Correlate of PA (n)

Reached PA-level (≥ 5p)

% of patients

p valuea

phi coefficient

Positive values

Negative values

  

SEE (171/115)

44.4

38.7

0.294

0.06

PREP (183/165)

47.0

37.6

0.076

0.10

CONF (180/167)

48.3

35.9

0.019

0.12

BMI (131/226)

50.4

39.4

0.043

0.11

PCS (182/162)

46.2

37.7

0.111

0.09

SEE/PREP (109/92)

49.5

38.0

0.102

0.12

SEE/CONF (107/94)

47.7

34.0

0.050

0.14

SEE/BMI (70/106)

54.3

37.7

0.031

0.16

SEE/PCS (96/79)

47.9

34.2

0.067

0.14

PREP/CONF (128/112)

49.2

33.0

0.011

0.16

PREP/BMI (62/100)

53.2

32.0

0.007

0.21

PREP/PCS (101/80)

50.5

33.8

0.024

0.17

CONF/BMI (65/105)

50.8

28.6

0.004

0.22

CONF/PCS (103/85)

51.5

31.8

0.007

0.20

BMI/PCS (78/113)

48.7

31.9

0.019

0.17

 

Low values

High values

  

PABL (70/85)

38.7

47.2

0.101

0.09

  1. PA-level physical activity level according to ACSM/AHA questionnaire, SEE self-efficacy expectations, PREP readiness to change – prepared, CONF readiness to change – confident, BMI body max index, PCS physical component summary – SF-36, PABL physical activity at baseline. Cut-points regarding positively assessed values were: SEE ≥4.77 points, PREP > 86 mm, CONF > 68 mm, BMI < 30, PCS ≥ 47.06 points. Cut-point regarding low PABL was < 2 points
  2. aP values were determined by Chi-square test for independence
  3. Statistical significance was set at p ≤ 0.05. Statistical significant p-values are presented in bold numbers